Reuters logo
BRIEF-Almirall: study confirms efficacy of Sativex in treating multiple sclerosis spasticity
October 27, 2017 / 7:43 AM / 22 days ago

BRIEF-Almirall: study confirms efficacy of Sativex in treating multiple sclerosis spasticity

Oct 27 (Reuters) - ALMIRALL SA:

* SAYS STUDY CONFIRMS EFFICACY AND TOLERABILITY OF SATIVEX IN TREATMENT OF MULTIPLE SCLEROSIS SPASTICITY RESISTANT PATIENTS Source text: bit.ly/2yPWT4P Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below